APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platinum-based Anticancer Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Platinum-based Anticancer Drugs Market Analysis and Forecast 2026-2032

20 December 2025202 pages

Choose your research edition.

Industry ResearchPlatinum-based Anticancer Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Platinum-based Anticancer Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Platinum-based Anticancer Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platinum-based Anticancer Drugs Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Platinum-based Anticancer Drugs Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Platinum-based Anticancer Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Platinum-based Anticancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Platinum-based Anticancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Platinum-based Anticancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Platinum-based Anticancer Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Platinum-based Anticancer Drugs include Teva, Sun Pharmaceutical, Qilu Pharmaceutical, Nanjing Pharmaceutical Factory, Mylan, Luoxin, Jiangsu Aosaikang Pharmaceutical, Jiangsu Hengrui Medicine and Fresenius Kabi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Platinum-based Anticancer Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Platinum-based Anticancer Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Platinum-based Anticancer Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Platinum-based Anticancer Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Platinum-based Anticancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Platinum-based Anticancer Drugs sales, projected growth trends, production technology, application and end-user industry.

Platinum-based Anticancer Drugs Segment by Company

Teva

Sun Pharmaceutical

Qilu Pharmaceutical

Nanjing Pharmaceutical Factory

Mylan

Luoxin

Jiangsu Aosaikang Pharmaceutical

Jiangsu Hengrui Medicine

Fresenius Kabi

Yakult honsha

Taj Pharmaceuticals

Sanofi-Aventis

Lingnan Pharmacy

Hospira(Pfizer)

Hisun Pharmaceutical

Hansoh Pharma

Dr Reddy's laboratories

Platinum-based Anticancer Drugs Segment by Type

Oxaliplatin

Carboplatin

Nedaplatin

Cisplatin

Others

Platinum-based Anticancer Drugs Segment by Application

Esophageal Cancer

Breast Cancer

Osteosarcoma

Testicular Cancer

NSCLC

Other

Platinum-based Anticancer Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum-based Anticancer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platinum-based Anticancer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum-based Anticancer Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Platinum-based Anticancer Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Platinum-based Anticancer Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oxaliplatin Major Manufacturers Table 3. Carboplatin Major Manufacturers Table 4. Nedaplatin Major Manufacturers Table 5. Cisplatin Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Esophageal Cancer Major Manufacturers Table 9. Breast Cancer Major Manufacturers Table 10. Osteosarcoma Major Manufacturers Table 11. Testicular Cancer Major Manufacturers Table 12. NSCLC Major Manufacturers Table 13. Other Major Manufacturers Table 14. Platinum-based Anticancer Drugs Industry Trends Table 15. Platinum-based Anticancer Drugs Industry Drivers Table 16. Platinum-based Anticancer Drugs Industry Opportunities and Challenges Table 17. Platinum-based Anticancer Drugs Industry Restraints Table 18. Global Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Platinum-based Anticancer Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Platinum-based Anticancer Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2021-2026) Table 22. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2027-2032) Table 23. Global Platinum-based Anticancer Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Platinum-based Anticancer Drugs Sales by Region (2021-2026) & (Tons) Table 25. Global Platinum-based Anticancer Drugs Sales by Region (2027-2032) & (Tons) Table 26. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2021-2026) Table 27. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2027-2032) Table 28. Global Platinum-based Anticancer Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Platinum-based Anticancer Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global Platinum-based Anticancer Drugs Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Platinum-based Anticancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Platinum-based Anticancer Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Platinum-based Anticancer Drugs Manufacturers, Product Type & Application Table 36. Global Platinum-based Anticancer Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Platinum-based Anticancer Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Platinum-based Anticancer Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2026) Table 43. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2027-2032) Table 44. Global Platinum-based Anticancer Drugs Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 45. Global Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 46. Global Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 47. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2026) Table 48. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2027-2032) Table 49. Global Platinum-based Anticancer Drugs Price by Type (2021-2026) & (US$/Ton) Table 50. Global Platinum-based Anticancer Drugs Price by Type (2027-2032) & (US$/Ton) Table 51. Global Platinum-based Anticancer Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2026) Table 55. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2027-2032) Table 56. Global Platinum-based Anticancer Drugs Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 57. Global Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 58. Global Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 59. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2026) Table 60. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2027-2032) Table 61. Global Platinum-based Anticancer Drugs Price by Application (2021-2026) & (US$/Ton) Table 62. Global Platinum-based Anticancer Drugs Price by Application (2027-2032) & (US$/Ton) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Teva Platinum-based Anticancer Drugs Product Portfolio Table 67. Teva Recent Development Table 68. Sun Pharmaceutical Company Information Table 69. Sun Pharmaceutical Business Overview Table 70. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 72. Sun Pharmaceutical Recent Development Table 73. Qilu Pharmaceutical Company Information Table 74. Qilu Pharmaceutical Business Overview Table 75. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 77. Qilu Pharmaceutical Recent Development Table 78. Nanjing Pharmaceutical Factory Company Information Table 79. Nanjing Pharmaceutical Factory Business Overview Table 80. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio Table 82. Nanjing Pharmaceutical Factory Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Mylan Platinum-based Anticancer Drugs Product Portfolio Table 87. Mylan Recent Development Table 88. Luoxin Company Information Table 89. Luoxin Business Overview Table 90. Luoxin Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Luoxin Platinum-based Anticancer Drugs Product Portfolio Table 92. Luoxin Recent Development Table 93. Jiangsu Aosaikang Pharmaceutical Company Information Table 94. Jiangsu Aosaikang Pharmaceutical Business Overview Table 95. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 97. Jiangsu Aosaikang Pharmaceutical Recent Development Table 98. Jiangsu Hengrui Medicine Company Information Table 99. Jiangsu Hengrui Medicine Business Overview Table 100. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio Table 102. Jiangsu Hengrui Medicine Recent Development Table 103. Fresenius Kabi Company Information Table 104. Fresenius Kabi Business Overview Table 105. Fresenius Kabi Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio Table 107. Fresenius Kabi Recent Development Table 108. Yakult honsha Company Information Table 109. Yakult honsha Business Overview Table 110. Yakult honsha Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Yakult honsha Platinum-based Anticancer Drugs Product Portfolio Table 112. Yakult honsha Recent Development Table 113. Taj Pharmaceuticals Company Information Table 114. Taj Pharmaceuticals Business Overview Table 115. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio Table 117. Taj Pharmaceuticals Recent Development Table 118. Sanofi-Aventis Company Information Table 119. Sanofi-Aventis Business Overview Table 120. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio Table 122. Sanofi-Aventis Recent Development Table 123. Lingnan Pharmacy Company Information Table 124. Lingnan Pharmacy Business Overview Table 125. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio Table 127. Lingnan Pharmacy Recent Development Table 128. Hospira(Pfizer) Company Information Table 129. Hospira(Pfizer) Business Overview Table 130. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio Table 132. Hospira(Pfizer) Recent Development Table 133. Hisun Pharmaceutical Company Information Table 134. Hisun Pharmaceutical Business Overview Table 135. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio Table 137. Hisun Pharmaceutical Recent Development Table 138. Hansoh Pharma Company Information Table 139. Hansoh Pharma Business Overview Table 140. Hansoh Pharma Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio Table 142. Hansoh Pharma Recent Development Table 143. Dr Reddy's laboratories Company Information Table 144. Dr Reddy's laboratories Business Overview Table 145. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio Table 147. Dr Reddy's laboratories Recent Development Table 148. North America Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 151. North America Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 152. North America Platinum-based Anticancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 153. North America Platinum-based Anticancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 154. North America Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 157. North America Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 158. North America Platinum-based Anticancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 159. North America Platinum-based Anticancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 160. North America Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. North America Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. North America Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 164. North America Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 165. North America Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 166. North America Platinum-based Anticancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 167. North America Platinum-based Anticancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 168. United States Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 169. Canada Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 170. Europe Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 173. Europe Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 174. Europe Platinum-based Anticancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 175. Europe Platinum-based Anticancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 176. Europe Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 179. Europe Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 180. Europe Platinum-based Anticancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 181. Europe Platinum-based Anticancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 182. Europe Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 186. Europe Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 187. Europe Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 188. Europe Platinum-based Anticancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 189. Europe Platinum-based Anticancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 190. Germany Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 191. France Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 192. U.K. Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 193. Italy Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 194. Netherlands Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 195. China Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 196. China Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 197. China Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 198. China Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 199. China Platinum-based Anticancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 200. China Platinum-based Anticancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 201. China Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. China Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. China Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 204. China Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 205. China Platinum-based Anticancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 206. China Platinum-based Anticancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 207. Asia Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 210. Asia Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 211. Asia Platinum-based Anticancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 212. Asia Platinum-based Anticancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 213. Asia Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 216. Asia Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 217. Asia Platinum-based Anticancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 218. Asia Platinum-based Anticancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 219. Asia Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 223. Asia Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 224. Asia Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 225. Asia Platinum-based Anticancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 226. Asia Platinum-based Anticancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 227. Japan Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 228. South Korea Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 229. India Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 230. Australia Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 231. China Taiwan Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Platinum-based Anticancer Drugs Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Platinum-based Anticancer Drugs Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Platinum-based Anticancer Drugs Sales by Type (2021-2026) & (Tons) Table 236. SAMEA Platinum-based Anticancer Drugs Sales by Type (2027-2032) & (Tons) Table 237. SAMEA Platinum-based Anticancer Drugs Sales Price by Type (2021-2026) & (US$/Ton) Table 238. SAMEA Platinum-based Anticancer Drugs Sales Price by Type (2027-2032) & (US$/Ton) Table 239. SAMEA Platinum-based Anticancer Drugs Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Platinum-based Anticancer Drugs Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Platinum-based Anticancer Drugs Sales by Application (2021-2026) & (Tons) Table 242. SAMEA Platinum-based Anticancer Drugs Sales by Application (2027-2032) & (Tons) Table 243. SAMEA Platinum-based Anticancer Drugs Sales Price by Application (2021-2026) & (US$/Ton) Table 244. SAMEA Platinum-based Anticancer Drugs Sales Price by Application (2027-2032) & (US$/Ton) Table 245. SAMEA Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 249. SAMEA Platinum-based Anticancer Drugs Sales by Country (2021-2026) & (Tons) Table 250. SAMEA Platinum-based Anticancer Drugs Sales by Country (2027-2032) & (Tons) Table 251. SAMEA Platinum-based Anticancer Drugs Sales Price by Country (2021-2026) & (US$/Ton) Table 252. SAMEA Platinum-based Anticancer Drugs Sales Price by Country (2027-2032) & (US$/Ton) Table 253. Brazil Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 254. Argentina Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 255. Chile Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 256. Colombia Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 257. Peru Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 259. Israel Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 260. UAE Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 261. Turkey Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 262. Iran Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 263. Egypt Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Platinum-based Anticancer Drugs Distributors List Table 267. Platinum-based Anticancer Drugs Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Platinum-based Anticancer Drugs Image Figure 2. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Platinum-based Anticancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oxaliplatin Image Figure 5. Carboplatin Image Figure 6. Nedaplatin Image Figure 7. Cisplatin Image Figure 8. Others Image Figure 9. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Platinum-based Anticancer Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Esophageal Cancer Image Figure 12. Breast Cancer Image Figure 13. Osteosarcoma Image Figure 14. Testicular Cancer Image Figure 15. NSCLC Image Figure 16. Other Image Figure 17. Global Platinum-based Anticancer Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Platinum-based Anticancer Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global Platinum-based Anticancer Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Platinum-based Anticancer Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global Platinum-based Anticancer Drugs Sales (2021-2032) & (Tons) Figure 23. Global Platinum-based Anticancer Drugs Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 24. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Platinum-based Anticancer Drugs Sales YoY (2021-2032) & (Tons) Figure 26. Europe Platinum-based Anticancer Drugs Sales YoY (2021-2032) & (Tons) Figure 27. China Platinum-based Anticancer Drugs Sales YoY (2021-2032) & (Tons) Figure 28. Asia (Excluding China) Platinum-based Anticancer Drugs Sales YoY (2021-2032) & (Tons) Figure 29. South America, Middle East and Africa Platinum-based Anticancer Drugs Sales YoY (2021-2032) & (Tons) Figure 30. Global Platinum-based Anticancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Platinum-based Anticancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Platinum-based Anticancer Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Platinum-based Anticancer Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global Platinum-based Anticancer Drugs Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Platinum-based Anticancer Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2032) Figure 39. Global Platinum-based Anticancer Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Platinum-based Anticancer Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global Platinum-based Anticancer Drugs Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 43. Global Platinum-based Anticancer Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2032) Figure 45. North America Platinum-based Anticancer Drugs Revenue Share by Type (2021-2032) Figure 46. North America Platinum-based Anticancer Drugs Sales Share by Type (2021-2032) Figure 47. North America Platinum-based Anticancer Drugs Revenue Share by Application (2021-2032) Figure 48. North America Platinum-based Anticancer Drugs Sales Share by Application (2021-2032) Figure 49. North America Platinum-based Anticancer Drugs Revenue Share by Country (2021-2032) Figure 50. North America Platinum-based Anticancer Drugs Sales Share by Country (2021-2032) Figure 51. Europe Platinum-based Anticancer Drugs Revenue Share by Type (2021-2032) Figure 52. Europe Platinum-based Anticancer Drugs Sales Share by Type (2021-2032) Figure 53. Europe Platinum-based Anticancer Drugs Revenue Share by Application (2021-2032) Figure 54. Europe Platinum-based Anticancer Drugs Sales Share by Application (2021-2032) Figure 55. Europe Platinum-based Anticancer Drugs Revenue Share by Country (2021-2032) Figure 56. Europe Platinum-based Anticancer Drugs Sales Share by Country (2021-2032) Figure 57. China Platinum-based Anticancer Drugs Revenue Share by Type (2021-2032) Figure 58. China Platinum-based Anticancer Drugs Sales Share by Type (2021-2032) Figure 59. China Platinum-based Anticancer Drugs Revenue Share by Application (2021-2032) Figure 60. China Platinum-based Anticancer Drugs Sales Share by Application (2021-2032) Figure 61. Asia Platinum-based Anticancer Drugs Revenue Share by Type (2021-2032) Figure 62. Asia Platinum-based Anticancer Drugs Sales Share by Type (2021-2032) Figure 63. Asia Platinum-based Anticancer Drugs Revenue Share by Application (2021-2032) Figure 64. Asia Platinum-based Anticancer Drugs Sales Share by Application (2021-2032) Figure 65. Asia Platinum-based Anticancer Drugs Revenue Share by Country (2021-2032) Figure 66. Asia Platinum-based Anticancer Drugs Sales Share by Country (2021-2032) Figure 67. SAMEA Platinum-based Anticancer Drugs Revenue Share by Type (2021-2032) Figure 68. SAMEA Platinum-based Anticancer Drugs Sales Share by Type (2021-2032) Figure 69. SAMEA Platinum-based Anticancer Drugs Revenue Share by Application (2021-2032) Figure 70. SAMEA Platinum-based Anticancer Drugs Sales Share by Application (2021-2032) Figure 71. SAMEA Platinum-based Anticancer Drugs Revenue Share by Country (2021-2032) Figure 72. SAMEA Platinum-based Anticancer Drugs Sales Share by Country (2021-2032) Figure 73. Platinum-based Anticancer Drugs Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Platinum-based Anticancer Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Oxaliplatin
  • Carboplatin
  • Nedaplatin
  • Cisplatin
  • Others
Applications
  • Esophageal Cancer
  • Breast Cancer
  • Osteosarcoma
  • Testicular Cancer
  • NSCLC
  • Other
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Qilu Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Mylan
  • Luoxin
  • Jiangsu Aosaikang Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Fresenius Kabi
  • Yakult honsha
  • Taj Pharmaceuticals
  • Sanofi-Aventis
  • Lingnan Pharmacy
  • Hospira(Pfizer)
  • Hisun Pharmaceutical
  • Hansoh Pharma
  • Dr Reddy's laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Platinum-based Anticancer Drugs Market by Type
  3. 1.2.1 Global Platinum-based Anticancer Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oxaliplatin
  5. 1.2.3 Carboplatin
  6. 1.2.4 Nedaplatin
  7. 1.2.5 Cisplatin
  8. 1.2.6 Others
  9. 1.3 Platinum-based Anticancer Drugs Market by Application
  10. 1.3.1 Global Platinum-based Anticancer Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Esophageal Cancer
  12. 1.3.3 Breast Cancer
  13. 1.3.4 Osteosarcoma
  14. 1.3.5 Testicular Cancer
  15. 1.3.6 NSCLC
  16. 1.3.7 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Platinum-based Anticancer Drugs Market Dynamics
  1. 2.1 Platinum-based Anticancer Drugs Industry Trends
  2. 2.2 Platinum-based Anticancer Drugs Industry Drivers
  3. 2.3 Platinum-based Anticancer Drugs Industry Opportunities and Challenges
  4. 2.4 Platinum-based Anticancer Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Platinum-based Anticancer Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Platinum-based Anticancer Drugs Revenue by Region
  3. 3.2.1 Global Platinum-based Anticancer Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Platinum-based Anticancer Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Platinum-based Anticancer Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Platinum-based Anticancer Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Platinum-based Anticancer Drugs Sales by Region
  9. 3.4.1 Global Platinum-based Anticancer Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Platinum-based Anticancer Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Platinum-based Anticancer Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Platinum-based Anticancer Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Platinum-based Anticancer Drugs Revenue by Manufacturers
  2. 4.1.1 Global Platinum-based Anticancer Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Platinum-based Anticancer Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Platinum-based Anticancer Drugs Sales by Manufacturers
  6. 4.2.1 Global Platinum-based Anticancer Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Platinum-based Anticancer Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Platinum-based Anticancer Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Platinum-based Anticancer Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Platinum-based Anticancer Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Platinum-based Anticancer Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Platinum-based Anticancer Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Platinum-based Anticancer Drugs Market CR5 and HHI
  16. 4.8.2 2025 Platinum-based Anticancer Drugs Tier 1, Tier 2, and Tier 3
5 Platinum-based Anticancer Drugs Market by Type
  1. 5.1 Global Platinum-based Anticancer Drugs Revenue by Type
  2. 5.1.1 Global Platinum-based Anticancer Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Platinum-based Anticancer Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Platinum-based Anticancer Drugs Sales by Type
  6. 5.2.1 Global Platinum-based Anticancer Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Platinum-based Anticancer Drugs Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Platinum-based Anticancer Drugs Price by Type
6 Platinum-based Anticancer Drugs Market by Application
  1. 6.1 Global Platinum-based Anticancer Drugs Revenue by Application
  2. 6.1.1 Global Platinum-based Anticancer Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Platinum-based Anticancer Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Platinum-based Anticancer Drugs Sales by Application
  6. 6.2.1 Global Platinum-based Anticancer Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Platinum-based Anticancer Drugs Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Platinum-based Anticancer Drugs Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Platinum-based Anticancer Drugs Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Nanjing Pharmaceutical Factory
  20. 7.4.1 Nanjing Pharmaceutical Factory Company Information
  21. 7.4.2 Nanjing Pharmaceutical Factory Business Overview
  22. 7.4.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Portfolio
  24. 7.4.5 Nanjing Pharmaceutical Factory Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Platinum-based Anticancer Drugs Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Luoxin
  32. 7.6.1 Luoxin Company Information
  33. 7.6.2 Luoxin Business Overview
  34. 7.6.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Luoxin Platinum-based Anticancer Drugs Product Portfolio
  36. 7.6.5 Luoxin Recent Developments
  37. 7.7 Jiangsu Aosaikang Pharmaceutical
  38. 7.7.1 Jiangsu Aosaikang Pharmaceutical Company Information
  39. 7.7.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  40. 7.7.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  42. 7.7.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  43. 7.8 Jiangsu Hengrui Medicine
  44. 7.8.1 Jiangsu Hengrui Medicine Company Information
  45. 7.8.2 Jiangsu Hengrui Medicine Business Overview
  46. 7.8.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Portfolio
  48. 7.8.5 Jiangsu Hengrui Medicine Recent Developments
  49. 7.9 Fresenius Kabi
  50. 7.9.1 Fresenius Kabi Company Information
  51. 7.9.2 Fresenius Kabi Business Overview
  52. 7.9.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Portfolio
  54. 7.9.5 Fresenius Kabi Recent Developments
  55. 7.10 Yakult honsha
  56. 7.10.1 Yakult honsha Company Information
  57. 7.10.2 Yakult honsha Business Overview
  58. 7.10.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yakult honsha Platinum-based Anticancer Drugs Product Portfolio
  60. 7.10.5 Yakult honsha Recent Developments
  61. 7.11 Taj Pharmaceuticals
  62. 7.11.1 Taj Pharmaceuticals Company Information
  63. 7.11.2 Taj Pharmaceuticals Business Overview
  64. 7.11.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Portfolio
  66. 7.11.5 Taj Pharmaceuticals Recent Developments
  67. 7.12 Sanofi-Aventis
  68. 7.12.1 Sanofi-Aventis Company Information
  69. 7.12.2 Sanofi-Aventis Business Overview
  70. 7.12.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Portfolio
  72. 7.12.5 Sanofi-Aventis Recent Developments
  73. 7.13 Lingnan Pharmacy
  74. 7.13.1 Lingnan Pharmacy Company Information
  75. 7.13.2 Lingnan Pharmacy Business Overview
  76. 7.13.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Portfolio
  78. 7.13.5 Lingnan Pharmacy Recent Developments
  79. 7.14 Hospira(Pfizer)
  80. 7.14.1 Hospira(Pfizer) Company Information
  81. 7.14.2 Hospira(Pfizer) Business Overview
  82. 7.14.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Portfolio
  84. 7.14.5 Hospira(Pfizer) Recent Developments
  85. 7.15 Hisun Pharmaceutical
  86. 7.15.1 Hisun Pharmaceutical Company Information
  87. 7.15.2 Hisun Pharmaceutical Business Overview
  88. 7.15.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Portfolio
  90. 7.15.5 Hisun Pharmaceutical Recent Developments
  91. 7.16 Hansoh Pharma
  92. 7.16.1 Hansoh Pharma Company Information
  93. 7.16.2 Hansoh Pharma Business Overview
  94. 7.16.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Portfolio
  96. 7.16.5 Hansoh Pharma Recent Developments
  97. 7.17 Dr Reddy's laboratories
  98. 7.17.1 Dr Reddy's laboratories Company Information
  99. 7.17.2 Dr Reddy's laboratories Business Overview
  100. 7.17.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Portfolio
  102. 7.17.5 Dr Reddy's laboratories Recent Developments
8 North America
  1. 8.1 North America Platinum-based Anticancer Drugs Market Size by Type
  2. 8.1.1 North America Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Platinum-based Anticancer Drugs Price by Type (2021-2032)
  5. 8.2 North America Platinum-based Anticancer Drugs Market Size by Application
  6. 8.2.1 North America Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Platinum-based Anticancer Drugs Price by Application (2021-2032)
  9. 8.3 North America Platinum-based Anticancer Drugs Market Size by Country
  10. 8.3.1 North America Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Platinum-based Anticancer Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Platinum-based Anticancer Drugs Market Size by Type
  2. 9.1.1 Europe Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Platinum-based Anticancer Drugs Price by Type (2021-2032)
  5. 9.2 Europe Platinum-based Anticancer Drugs Market Size by Application
  6. 9.2.1 Europe Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Platinum-based Anticancer Drugs Price by Application (2021-2032)
  9. 9.3 Europe Platinum-based Anticancer Drugs Market Size by Country
  10. 9.3.1 Europe Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Platinum-based Anticancer Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Platinum-based Anticancer Drugs Market Size by Type
  2. 10.1.1 China Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Platinum-based Anticancer Drugs Price by Type (2021-2032)
  5. 10.2 China Platinum-based Anticancer Drugs Market Size by Application
  6. 10.2.1 China Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Platinum-based Anticancer Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Platinum-based Anticancer Drugs Market Size by Type
  2. 11.1.1 Asia Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Platinum-based Anticancer Drugs Price by Type (2021-2032)
  5. 11.2 Asia Platinum-based Anticancer Drugs Market Size by Application
  6. 11.2.1 Asia Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Platinum-based Anticancer Drugs Price by Application (2021-2032)
  9. 11.3 Asia Platinum-based Anticancer Drugs Market Size by Country
  10. 11.3.1 Asia Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Platinum-based Anticancer Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Platinum-based Anticancer Drugs Market Size by Type
  2. 12.1.1 SAMEA Platinum-based Anticancer Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Platinum-based Anticancer Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Platinum-based Anticancer Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Platinum-based Anticancer Drugs Market Size by Application
  6. 12.2.1 SAMEA Platinum-based Anticancer Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Platinum-based Anticancer Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Platinum-based Anticancer Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Platinum-based Anticancer Drugs Market Size by Country
  10. 12.3.1 SAMEA Platinum-based Anticancer Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Platinum-based Anticancer Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Platinum-based Anticancer Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Platinum-based Anticancer Drugs Value Chain Analysis
  2. 13.1.1 Platinum-based Anticancer Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Platinum-based Anticancer Drugs Production Mode & Process
  6. 13.2 Platinum-based Anticancer Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Platinum-based Anticancer Drugs Distributors
  9. 13.2.3 Platinum-based Anticancer Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst